AI-driven Alternative Medicine: A Novel Approach to Drug Discovery and Repurposing
Oleksandr Bilokon, Nataliya Bilokon, Paul Bilokon

TL;DR
AIAltMed is an innovative platform leveraging Tanimoto similarity for drug discovery and repurposing, aiming to enhance alternative medicine approaches through AI-driven methods and system integration strategies.
Contribution
It introduces AIAltMed, a novel AI-based platform for drug discovery and repurposing using Tanimoto similarity, and discusses system architecture and extension strategies.
Findings
Tanimoto similarity effectively identifies structurally similar compounds.
AIAltMed offers a new approach to drug repurposing in alternative medicine.
System architecture supports integration with PubChem database.
Abstract
AIAltMed is a cutting-edge platform designed for drug discovery and repurposing. It utilizes Tanimoto similarity to identify structurally similar non-medicinal compounds to known medicinal ones. This preprint introduces AIAltMed, discusses the concept of `AI-driven alternative medicine,' evaluates Tanimoto similarity's advantages and limitations, and details the system's architecture. Furthermore, it explores the benefits of extending the system to include PubChem and outlines a corresponding implementation strategy.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNutrition, Genetics, and Disease
